l-carnitine and prostate cancer Lipid Metabolism Modulatory Cisplatin Prodrug
Lipid Metabolism Modulatory Cisplatin Prodrug Sensitizes Resistant Prostate Cancer toward Androgen Deprivation Therapy ACS Pharmacology & Translational Science Dysfunction of the carnitine cycle in tumor progression: Heliyon Acetyl l carnitine is an anti angiogenic agent targeting the VEGFR2 and CXCR4 pathways ScienceDirect The carnitine system and cancer metabolic plasticity Cell Death & Disease
Pay in 4 interest-free payments of $7.45 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



